Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -9.7x - -10.7x | -10.2x |
| Selected Fwd P/E Multiple | 18.4x - 20.3x | 19.4x |
| Fair Value | €65.88 - €72.82 | €69.35 |
| Upside | -23.2% - -15.1% | -19.1% |
| Benchmarks | - | Full Ticker |
| Azenta, Inc. | - | NasdaqGS:AZTA |
| Bio-Rad Laboratories, Inc. | - | NYSE:BIO.B |
| Personalis, Inc. | - | NasdaqGM:PSNL |
| Waters Corporation | - | NYSE:WAT |
| Telesis Bio, Inc. | - | OTCPK:TBIO |
| Illumina, Inc. | - | DB:ILU |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| AZTA | BIO.B | PSNL | WAT | TBIO | ILU | |||
| NasdaqGS:AZTA | NYSE:BIO.B | NasdaqGM:PSNL | NYSE:WAT | OTCPK:TBIO | DB:ILU | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | 1.5% | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | -2.7% | NM- | NM- | ||
| Latest Twelve Months | -630.5% | -571.3% | 9.2% | 8.9% | -27.7% | 25.1% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 84.5% | 16.3% | -105.6% | 22.9% | -240.7% | -20.7% | ||
| Prior Fiscal Year | -1.9% | -23.9% | -147.4% | 21.7% | -176.7% | -25.8% | ||
| Latest Fiscal Year | -25.0% | -71.9% | -96.1% | 21.6% | -178.2% | -28.0% | ||
| Latest Twelve Months | -25.2% | -85.2% | -98.1% | 22.0% | -278.5% | -28.0% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 39.0x | 3.9x | -8.4x | 21.4x | -1.5x | 19.2x | ||
| Price / LTM Sales | 2.3x | 2.7x | 7.1x | 7.0x | 0.0x | 2.8x | ||
| LTM P/E Ratio | -9.3x | -3.2x | -7.3x | 32.0x | 0.0x | -10.1x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -9.3x | -3.2x | 32.0x | |||||
| Historical LTM P/E Ratio | -1500.6x | -5.2x | 77.4x | |||||
| Selected P/E Multiple | -9.7x | -10.2x | -10.7x | |||||
| (x) LTM Net Income | (966) | (966) | (966) | |||||
| (=) Equity Value | 9,394 | 9,888 | 10,383 | |||||
| (/) Shares Outstanding | 158.3 | 158.3 | 158.3 | |||||
| Implied Value Range | 59.34 | 62.46 | 65.59 | |||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | ||||
| Implied Value Range (Trading Cur) | 50.77 | 53.44 | 56.12 | 85.74 | ||||
| Upside / (Downside) | -40.8% | -37.7% | -34.5% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | AZTA | BIO.B | PSNL | WAT | TBIO | ILU | |
| Value of Common Equity | 1,532 | 7,014 | 563 | 21,001 | 1 | 15,863 | |
| (/) Shares Outstanding | 45.8 | 27.2 | 88.3 | 59.5 | 1.8 | 158.3 | |
| Implied Stock Price | 33.47 | 257.75 | 6.37 | 352.91 | 0.30 | 100.21 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |
| Implied Stock Price (Trading Cur) | 33.47 | 257.75 | 6.37 | 352.91 | 0.30 | 85.74 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |